Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Ji Yang

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Journal of Thoracic Disease|September 19, 2015
Clinical efficacy of crizotinib in Chinese patients with ALK-positive non-small-cell lung cancer with brain metastasesYuan-Yuan Lei, Jin-Ji Yang, Wen-Zhao Zhong, et al.
Journal of Cancer Research and Clinical Oncology|July 15, 2022
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomesChang Lu, Xue-Wu Wei, Yi-Chen Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical TrialJin-Ji Yang, Qing Zhou, Ri-Qiang Liao, et al.
Journal of Thoracic Disease|November 19, 2020
Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancerXin Gao, Xue-Wu Wei, Ming-Ying Zheng, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2015
A family history of cancer and lung cancer risk in never-smokers: A clinic-based case-control studyHuan Lin, Yi-Sheng Huang, Hong-hong Yan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2013
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: post hoc analyses from the IPASS studyYi-Long Wu, Masahiro Fukuoka, Tony S K Mok, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|April 21, 2007
[Gefitinib target treatment in non-small cell lung cancer]Yi-long Wu, Jin-ji Yang, Jia-ying Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2014
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patientsZhen Wang, Hong-Hong Yan, Jin-Ji Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 30, 2020
Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLCMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
The Journal of International Medical Research|December 16, 2025
Comparing the effect of traditional and novel tyrosine kinase inhibitors for epidermal growth factor receptor exon 20 insertions by molecular dynamics simulationKe-Jun Liu, Tao Jiang, Quan-Quan Tan, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Journal of Thoracic Disease|September 19, 2015
Clinical efficacy of crizotinib in Chinese patients with ALK-positive non-small-cell lung cancer with brain metastasesYuan-Yuan Lei, Jin-Ji Yang, Wen-Zhao Zhong, et al.
Journal of Cancer Research and Clinical Oncology|July 15, 2022
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomesChang Lu, Xue-Wu Wei, Yi-Chen Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical TrialJin-Ji Yang, Qing Zhou, Ri-Qiang Liao, et al.
Journal of Thoracic Disease|November 19, 2020
Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancerXin Gao, Xue-Wu Wei, Ming-Ying Zheng, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2015
A family history of cancer and lung cancer risk in never-smokers: A clinic-based case-control studyHuan Lin, Yi-Sheng Huang, Hong-hong Yan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2013
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: post hoc analyses from the IPASS studyYi-Long Wu, Masahiro Fukuoka, Tony S K Mok, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|April 21, 2007
[Gefitinib target treatment in non-small cell lung cancer]Yi-long Wu, Jin-ji Yang, Jia-ying Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2014
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patientsZhen Wang, Hong-Hong Yan, Jin-Ji Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 30, 2020
Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLCMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
The Journal of International Medical Research|December 16, 2025
Comparing the effect of traditional and novel tyrosine kinase inhibitors for epidermal growth factor receptor exon 20 insertions by molecular dynamics simulationKe-Jun Liu, Tao Jiang, Quan-Quan Tan, et al.
Pageof 18